A drug derived from cannabis eases chronic lower back pain ... The study is the most rigorous to date to show clinically ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...

Federal officials approved a new non-opioid painkiller developed by a Boston pharmaceutical company on Thursday, calling it a “first-in-class” treatment that avoids the addictive risks of opioid-based ...

The U.S. Food and Drug Administration (FDA) created a major media stir last week when it announced the approval of suzetrigine (brand name Journavx), a unique new non-opioid, non-addictive drug for ...

For the last quarter century, one of the world’s most capable drug developers toiled to make a new, non-addictive kind of painkiller. The journey was fittingly excruciating. Pain, as Vertex ...

Chronic pain is one of the most common and expensive health problems in the nation, affecting an estimated one in five U.S. adults and costing around $600 billion each year in medical expenses, lost ...

In this week’s edition of InnovationRx, we look at risks of new vaccine restrictions, virtual clinical trials at the Mayo ...

A new kind of pain medication has been approved for sale by the Food and Drug Administration. It is being touted as an alternative to opioids. It works differently, and it is not addictive. NPR's Yuki ...

Vertex stock is significantly undervalued due to the underestimated potential of its pain treatment drug, VX-548, which could become a blockbuster. VX-548 has shown to be more effective than placebos ...